Jiuzhou Pharmaceutical(SH:603456) Xin Lang Cai Jing·2025-10-23 02:10Core Viewpoint - Jiuzhou Pharmaceutical's stock has experienced fluctuations, with a year-to-date increase of 41.44% but a recent decline of 5.71% over the past five trading days [1] Financial Performance - For the period of January to September 2025, Jiuzhou Pharmaceutical achieved a revenue of 4.16 billion yuan, representing a year-on-year growth of 4.92%. The net profit attributable to shareholders was 748 million yuan, reflecting an 18.51% increase compared to the previous year [2] Stock Market Activity - As of October 23, Jiuzhou Pharmaceutical's stock price was 18.65 yuan per share, with a market capitalization of 16.588 billion yuan. The stock saw a net outflow of 10.89 million yuan in principal funds, with significant selling pressure from large orders [1] - The company has appeared on the "Dragon and Tiger List" once this year, with a net purchase of 51.1 million yuan on April 15 [1] Shareholder Information - As of September 30, 2025, Jiuzhou Pharmaceutical had 59,200 shareholders, an increase of 10.22% from the previous period. The average number of circulating shares per shareholder decreased by 9.27% to 15,035 shares [2] - The top ten circulating shareholders include Hong Kong Central Clearing Limited and several mutual funds, with notable increases in holdings for some [3] Dividend Distribution - Since its A-share listing, Jiuzhou Pharmaceutical has distributed a total of 2.183 billion yuan in dividends, with 1.245 billion yuan distributed over the past three years [3]